1600 Amphitheatre Parkway, CA 94043

Alfa Cytology: Revolutionizing Cancer Drug Development - Premier Partner in Progress!

Alfa Cytology is a cutting-edge biotechnology company that excels in cancer drug development and preclinical research. Our skilled team of scientists, bioinformatics experts, and oncologists is dedicated to providing innovative cancer drug development services to enhance preclinical research and advance the field of oncology.

We provide comprehensive cancer drug development services to biopharmaceutical companies, research institutions, and other entities. By targeting different targets and using the most appropriate tumor models, we help reveal the molecular complexity of cancer, identify potential drug targets, and accelerate the innovation of new anticancer drugs. Our services include:


Cancer Therapy Development Services

  • Cancer Drug Development
  • Cancer Nanomedicine Development
  • Cancer Antibody Development
  • Cancer Vaccine Development
  • Cancer Gene Therapy Development
  • Cancer Cell Therapy Development
  • Cancer Peptide Therapeutics Development
  • Cancer Diagnostic Development

Cancer Modeling Services

  • In Vitro Cancer Model
    2D Tumor Model
    3D Tumor Model
  • In Vivo Cancer Model
    Xenograft Model
    Immuno-Oncology Tumor Model
    Spontaneous Tumor Model
    Genetically Modified Tumor Model

Alfa Cytology is committed to becoming a global leader in cancer services and drug development. Alfa Cytology is actively involved in various areas of biotechnology, including research on pancreatic cancer, brain tumors, breast cancer, bladder cancer, neoantigens, cancer vaccines, and more.

In addition to research services, Alfa Cytology offers expert consulting and advisory services that can provide valuable insights on study design, data analysis, and regulatory compliance to help clients achieve their research goals. Alfa Cytology’s expertise, state-of-the-art facilities, and unwavering commitment to excellence set it apart as a partner of choice for organizations seeking to advance their anti-cancer drug development programs. Contact us today to learn how our services can support your research efforts and drive significant progress in the fight against cancer.

Cancer R&D 2024

United Scientific Group has geared up to a next level with its 9th annual meeting on Cancer Research & Drug Development during Nov 18-20, 2024

Contact Us

Subscribe Us


© United Scientific Group.